122 related articles for article (PubMed ID: 21337565)
1. The promise of nanotechnology for solving clinical problems in breast cancer.
Grobmyer SR; Morse DL; Fletcher B; Gutwein LG; Sharma P; Krishna V; Frost SC; Moudgil BM; Brown SC
J Surg Oncol; 2011 Mar; 103(4):317-25. PubMed ID: 21337565
[TBL] [Abstract][Full Text] [Related]
2. Nanotechnology for breast cancer therapy.
Tanaka T; Decuzzi P; Cristofanilli M; Sakamoto JH; Tasciotti E; Robertson FM; Ferrari M
Biomed Microdevices; 2009 Feb; 11(1):49-63. PubMed ID: 18663578
[TBL] [Abstract][Full Text] [Related]
3. Impact of nanotechnology in breast cancer.
Haq AI; Zabkiewicz C; Grange P; Arya M
Expert Rev Anticancer Ther; 2009 Aug; 9(8):1021-4. PubMed ID: 19671020
[No Abstract] [Full Text] [Related]
4. Breast cancer therapy: the role of PET-CT in decision making.
Pons F; Duch J; Fuster D
Q J Nucl Med Mol Imaging; 2009 Apr; 53(2):210-23. PubMed ID: 19293769
[TBL] [Abstract][Full Text] [Related]
5. What is cancer nanotechnology?
Grobmyer SR; Iwakuma N; Sharma P; Moudgil BM
Methods Mol Biol; 2010; 624():1-9. PubMed ID: 20217585
[TBL] [Abstract][Full Text] [Related]
6. Impact of the diagnostic methods on the therapeutic strategies.
Greco M; Agresti R; Giovanazzi R
Q J Nucl Med; 1998 Mar; 42(1):66-80. PubMed ID: 9646647
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer--new and emerging technologies for diagnosis and management.
Houssami N; French J; Brennan M; Ahern V; Ung O
Aust Fam Physician; 2005 Aug; 34(8):657-61. PubMed ID: 16113703
[TBL] [Abstract][Full Text] [Related]
8. New Advances in Nanotechnology-Based Diagnosis and Therapeutics for Breast Cancer: An Assessment of Active-Targeting Inorganic Nanoplatforms.
Falagan-Lotsch P; Grzincic EM; Murphy CJ
Bioconjug Chem; 2017 Jan; 28(1):135-152. PubMed ID: 27973767
[TBL] [Abstract][Full Text] [Related]
9. Emerging nanopharmaceuticals.
Bawarski WE; Chidlowsky E; Bharali DJ; Mousa SA
Nanomedicine; 2008 Dec; 4(4):273-82. PubMed ID: 18640076
[TBL] [Abstract][Full Text] [Related]
10. [Needle aspiration cytology of the breast: current perspective on the role in diagnosis and management].
Kocjan G
Acta Med Croatica; 2008 Oct; 62(4):391-401. PubMed ID: 19205416
[TBL] [Abstract][Full Text] [Related]
11. Proteomics, morphoproteomics, saliva and breast cancer: an emerging approach to guide the delivery of individualised thermal therapy, thermochemotherapy and monitor therapy response.
Streckfus CF; Brown RE; Bull JM
Int J Hyperthermia; 2010; 26(7):649-61. PubMed ID: 20849260
[TBL] [Abstract][Full Text] [Related]
12. MR imaging: its current and potential utility in the diagnosis and management of breast cancer.
Kumar NA; Schnall MD
Magn Reson Imaging Clin N Am; 2000 Nov; 8(4):715-28. PubMed ID: 11149675
[TBL] [Abstract][Full Text] [Related]
13. Current management of breast cancer.
Phillips DM; Balducci L
Am Fam Physician; 1996 Feb; 53(2):657-65. PubMed ID: 8629545
[TBL] [Abstract][Full Text] [Related]
14. [Current status and future of diagnosis and therapy of breast cancer: introduction].
Nogaret JM
Rev Med Brux; 1995; 16(4):211-3. PubMed ID: 7481225
[TBL] [Abstract][Full Text] [Related]
15. Advances in novel drug delivery strategies for breast cancer therapy.
Dhankhar R; Vyas SP; Jain AK; Arora S; Rath G; Goyal AK
Artif Cells Blood Substit Immobil Biotechnol; 2010 Oct; 38(5):230-49. PubMed ID: 20677900
[TBL] [Abstract][Full Text] [Related]
16. The role of locoregional therapy in inflammatory breast cancer.
Woodward WA; Buchholz TA
Semin Oncol; 2008 Feb; 35(1):78-86. PubMed ID: 18308149
[TBL] [Abstract][Full Text] [Related]
17. Emerging implications of nanotechnology on cancer diagnostics and therapeutics.
Cuenca AG; Jiang H; Hochwald SN; Delano M; Cance WG; Grobmyer SR
Cancer; 2006 Aug; 107(3):459-66. PubMed ID: 16795065
[TBL] [Abstract][Full Text] [Related]
18. Metastatic breast cancer: understanding current management options.
McGinn K; Moore J
Oncol Nurs Forum; 2001 Apr; 28(3):507-12; quiz 513-4. PubMed ID: 11338758
[TBL] [Abstract][Full Text] [Related]
19. Improving decision-making in early breast cancer: who to treat and how?
Llombart-Cussac A
Breast Cancer Res Treat; 2008 Dec; 112 Suppl 1():15-24. PubMed ID: 19082929
[TBL] [Abstract][Full Text] [Related]
20. [Clinical guidelines for diagnosis, treatment and monitoring of patients with non-invasive breast cancer].
Brnijć Z; Brkljacić B; Drinković I; Jakić-Razumović J; Kardum-Skelin I; Krajina Z; Margaritoni M; Strnad M; Sarcević B; Tomić S; Zic R;
Lijec Vjesn; 2012; 134(9-10):259-65. PubMed ID: 23297509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
